Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991.

BACKGROUND During 1990 and 1991 a survey of immunity was carried out in Sweden. The main purpose was to estimate the level of immunity to diphtheria, tetanus and polio in the adult population. In total, 4800 people, randomly selected according to a stratified, two-stage, sampling plan, were contacted and asked to contribute a blood sample. Of those selected, 70.6% gave a blood sample. METHODS Estimates and confidence intervals of the proportion of the population with antibodies exceeding some titre was calculated. The population was divided according to sex, year of birth (five age groups) and residence (four regions). RESULTS In age groups that were born after the introduction of childhood vaccination, > or =90% and 75-90% of people have demonstrable antibodies at a protective level against tetanus and diphtheria respectively. Those born earlier, especially women, are poorly protected with less than 50% having protective antibody levels for both tetanus and diphtheria. Differences between men and women were particularly seen in the age groups born between 1930 and 1950. Less than 5% of the Swedish population lacked the protective level antibodies against polio types 1, 2 and 3 respectively. CONCLUSIONS Vaccination against tetanus, which can be combined with vaccination against diphtheria, can be recommended especially to women born before 1950 and with no documented previous vaccination. The same recommendation can be given for men born before the 1930s. As regards poliomyelitis, general booster vaccination of the adult population does not appear to be necessary at present.

[1]  M. Böttiger Antibody stimulation in individuals without demonstrable poliovirus antibodies following a fifth injection of inactivated poliovirus vaccine. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[2]  S. Diedrich,et al.  Immunitätslage gegen Poliomyelitis: Polio-Serosurveillance 1993 , 2008 .

[3]  P. Gergen,et al.  A population-based serologic survey of immunity to tetanus in the United States. , 1995, The New England journal of medicine.

[4]  G. Cilla,et al.  [Immunity against tetanus in adults over the age of 49 years]. , 1994, Medicina clinica.

[5]  V. Baldo,et al.  Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey. , 1994, Annals of clinical and laboratory science.

[6]  M. Böttiger,et al.  Swedish inactivated polio vaccine: laboratory standardization and clinical experience over a 30-year period. , 1992, Biologicals (Print).

[7]  L. M. Onotato MUCOSAL IMMUNITY INDUCED BY ENHANCED POTENCY INACTIVATED AND ORAL POLIO VACCINES , 1991 .

[8]  M. Böttiger Polio immunity to killed vaccine: an 18-year follow-up. , 1990, Vaccine.

[9]  J. Cuthie,et al.  Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. , 1988, American journal of epidemiology.

[10]  K. Cantell,et al.  OUTBREAK OF PARALYTIC POLIOMYELITIS IN FINLAND: WIDESPREAD CIRCULATION OF ANTIGENICALLY ALTERED POLIOVIRUS TYPE 3 IN A VACCINATED POPULATION , 1986, The Lancet.

[11]  H. Ericsson,et al.  Active Basal Immunity and Its Application to Epidemiology III. Combined Immunization against Diphtheria, Tetanus, and Pertussis in Infancy , 1954, Acta paediatrica.

[12]  H. Ericsson Studies on Tetanus Prophylaxis , 1948, Journal of clinical pathology.

[13]  J. Ipsen,et al.  Circulating antitoxin at the onset of diphtheria in 425 patients. , 1946, Journal of immunology.

[14]  H. Ericsson Purification and Adsorption of Diphtheria Toxoid , 1946, Nature.

[15]  Expanded programme on immunization. Diphtheria epidemic in the Newly Independent States of the former USSR, 1990-1994. , 1995, Releve epidemiologique hebdomadaire.

[16]  T. Rønne,et al.  Immunity from diphtheria, tetanus, poliomyelitis, measles, mumps and rubella among adults in Lithuania. , 1994, Scandinavian journal of infectious diseases.

[17]  J. Nagel,et al.  The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. , 1988, Journal of biological standardization.

[18]  B. Christenson,et al.  Epidemiology and immunity to tetanus in Sweden. , 1987, Scandinavian journal of infectious diseases.

[19]  O. Simonsen,et al.  Modification of the ELISA for the estimation of tetanus antitoxin in human sera. , 1987, Journal of biological standardization.

[20]  M. Böttiger A study of the sero-immunity that has protected the Swedish population against poliomyelitis for 25 years. , 1987, Scandinavian journal of infectious diseases.

[21]  O. Simonsen,et al.  ELISA for the routine determination of antitoxic immunity to tetanus. , 1986, Journal of biological standardization.

[22]  B. Christenson,et al.  Serological immunity to diphtheria in Sweden in 1978 and 1984. , 1986, Scandinavian Journal of Infectious Diseases.

[23]  K. Lapinleimu,et al.  Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. , 1981, Developments in biological standardization.

[24]  H. Söderström,et al.  Epidemiological events surrounding a paralytic case of poliomyelitis in Sweden. , 1979, Bulletin of the World Health Organization.

[25]  A. Griffith The role of immunization in the control of diphtheria. , 1979, Developments in biological standardization.

[26]  Griffith Ah The role of immunization in the control of diphtheria. , 1979 .

[27]  E. Eriksson,et al.  Active immunization against tetanus in man. I. Duration of anamnestic reaction after one dose of vaccine. , 1975, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[28]  E. Eriksson,et al.  Active Immunization against Tetanus in Man , 1975 .

[29]  K. Miyamura,et al.  Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. , 1974, Journal of biological standardization.

[30]  K. Miyamura,et al.  Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. , 1974, Journal of biological standardization.

[31]  M. Böttiger,et al.  Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years. , 1972, Bulletin of the World Health Organization.

[32]  I. Scheibel The uses and results of active tetanus immunization. , 1955, Bulletin of the World Health Organization.